Insulin Enquiry (Monopolies & Restrictive Practices Act): Copy Appendices to BIM Joint Memorandum and to BW&Co reply to Monopolies Commission

The file comprises:

Appendix 2: copy Agreement (22 November, 1947) between The Governors of the University of Toronto and Burroughs Wellcome & Co (USA) Inc.

Appendix 2A: copy Agreement (19 June, 1944) between The Wellcome Foundation Ltd and The British Drug Houses Ltd (and Allen & Hanburys Ltd).

Appendix 2B: correspondence (1944) between The Wellcome Foundation Ltd and The British Drug Houses Ltd and Allen & Hanburys Ltd.

Appendix 2C: correspondence (1944) between The Wellcome Foundation Ltd and Boots Pure Drug Co Ltd.

Appendix 3: copy Agreement (23 July, 1945) between The Wellcome Foundation Ltd and Boots Pure Drug Co Ltd.

Appendix 4: Appendix to Minutes to 41st Meeting of British Insulin Manufacturers (27 July, 1949).

There are no documents marked "Appendix 1" in the file.

The purpose of the Enquiry was to ensure that supplies of insulin were available to the diabetic community without interruption, despite the constraints of war. Manufacturers exchanged full technical information about their processes and visited each other's manufacturing plants.

1944-1949

1 file

WF/BIM.

Copyright assigned to the Wellcome Trust